Viacyte was founded in 1999, the headquarters are located in San Diego, California. It operates as a regenerative medicine company which focuses on producing cell replacement therapy (VC-01™),for severe diabetic sufferers. This company was originally known as Novocell but changed their name to Viacyte in 2010. Viacyte have many partners allowing them to expand further than their current focus on diabetes. Some of these partners include: ‘StemCell Technologies, JDRF and Cellular Dynamics International’.